Logo image

Pancreatic cancer treatment with targeted therapy

Pancreatic cancer treatment with targeted therapy
1
Media Files
1

Overview

Type of care

Outpatient

Method

Non-surgical

About the offer

Targeted therapy for pancreatic cancer blocks tumor growth by affecting specific molecules of malignant cells. As a result, targeted treatment makes it possible to eliminate the illness symptoms, prolong the patient's life and improve its quality. Before using targeted drugs, genetic studies of the tumor are performed. That makes choosing a drug that will give the maximum response to pancreatic cancer possible. Then, the oncologist advises the patient about treatment and tells him how to deal with side effects if they occur. Targeted drugs act differently than standard chemical ones. They find a specific target in the tumor cell – a mutation in the gene and the corresponding abnormal protein. When a target is detected, it is "attacked" and destroyed. The malignant pancreatic cell loses the ability to divide and grow. That is how targeted drugs fight cancer. The mechanism of therapy action specifically attacks cancer and does not harm healthy organs. That is critically important for patients who are already weakened by the disease. Most medications are injected intravenously. In this case, treatment is usually carried out in cycles. The patient is prescribed additional medications to minimize or eliminate targeted drugs' negative impact if necessary. Control examinations with imaging determine the effect of therapy.

What’s included

Medical service

Examination
  • clinical history-taking
  • medical records review
  • physical examination
  • consultation with a gastroenterologist-oncologist
Laboratory tests
  • complete blood count (CBC)
  • biochemical analysis of blood (kidney and liver function tests, electrolytes)
  • inflammation blood tests
  • C-peptide test
  • urinalysis
Diagnosis
  • ultrasound imaging of the abdomen
  • endoscopic ultrasound of the pancreatic gland
  • CT scan of the abdomen
  • histopathological specimen re-examination (on the indication, price is not included)
  • immunohistochemistry test (IHC) (on the indication, price is not included)
  • genetic mutation testing (on the indication, price is not included)
Treatment
  • pre-procedure patient preparation
  • 1st course of targeted therapy for pancreatic cancer
  • post-procedure care
  • symptomatic treatment
Other
  • cost of targeted drugs
  • cost of essential medicines
  • cost of essential materials
  • nursing service
  • discharge medical records
  • further recommendations

AiroCare

AiroMedical support
Payment protection
Patient advocacy
Price match

Customize this offer

If you're not seeing exactly what you need here, send your custom request. You can discuss the content, specifics, price & timeline to create a personalized plan.

FAQ

What is the cost?

The total price for Pancreatic cancer treatment with targeted therapy is €5,319. However, it can vary from the specifics of each case. Get in touch to get an individual estimate.

How long does the offer take?

The offer is designed for 5 days.

Does the offer require you to stay in the clinic overnight?

Where can I see the media files?

What are the age restrictions?

The offer is eligible for both adults and kids.

Can I customize the content of the offer?

Yes, the components of the deal can be changed. Get in touch with a vendor to create a personalized proposal.

Individual cost estimate. Non-binding 100% free assessment.

€5,319

Similar deals